Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers

Hariprasad, Gururao ; Hariprasad, Roopa ; Kumar, Lalit ; Srinivasan, Alagiri ; Kola, Srujana ; Kaushik, Amit (2013) Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers Biomarkers, 18 (6). pp. 532-541. ISSN 1354-750X

Full text not available from this repository.

Official URL: http://www.tandfonline.com/doi/abs/10.3109/1354750...

Related URL: http://dx.doi.org/10.3109/1354750X.2013.822561

Abstract

Context: Primary ovarian cancer and ovarian metastasis from non-ovarian cancers in advanced stage are closely mimicking conditions whose therapeutics and prognosis are different. Objective: To identify biomarkers that can differentiate the two variants of advanced ovarian cancers. Methods: Gel-based proteomics and antibody-based assays were used to study the differentially expressed proteins in the ascitic fluid of fourteen patients with advanced ovarian cancers. Results: Programmed Cell Death 1-Ligand 2, apolipoprotein A1, apolipoprotein A4 and anti-human fas antibody are differentially expressed proteins. Conclusions: Apolipoprotein A1 with a 61.8?ng/ml cut-off is a potential biomarker with the best differentiating statistical parameters.

Item Type:Article
Source:Copyright of this article belongs to Taylor and Francis Group.
Keywords:Gel-based Proteomics; Metastatic Ovarian Cancer; Primary Ovarian Cancer; Validation
ID Code:111210
Deposited On:25 Sep 2017 12:42
Last Modified:25 Sep 2017 12:42

Repository Staff Only: item control page